At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 20 enrolled
Drug / intervention
Apremilastdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy
In Brief
A Phase 4 clinical trial evaluating Apremilast for Plaque Psoriasis. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Sixteen week open label study of apremilast in combination with topical steroids with a four week safety follow up visit.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesUnited States
CollaboratorsCelgene
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedDec 2016
Enrollment StartDec 2016
Primary CompletionApr 2018
Study CompletionApr 2018
TodayJul 2026
First PostedDec 22, 2016
Enrollment StartDec 29, 2016
Primary CompletionApr 1, 2018
Study CompletionApr 25, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.5 years ago
Interventions
Apremilastdrug